Eric Baudin

3.9k total citations · 2 hit papers
27 papers, 1.9k citations indexed

About

Eric Baudin is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, Eric Baudin has authored 27 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 16 papers in Endocrinology, Diabetes and Metabolism and 15 papers in Cancer Research. Recurrent topics in Eric Baudin's work include Adrenal and Paraganglionic Tumors (18 papers), Cancer, Hypoxia, and Metabolism (14 papers) and Hormonal Regulation and Hypertension (8 papers). Eric Baudin is often cited by papers focused on Adrenal and Paraganglionic Tumors (18 papers), Cancer, Hypoxia, and Metabolism (14 papers) and Hormonal Regulation and Hypertension (8 papers). Eric Baudin collaborates with scholars based in France, Italy and Netherlands. Eric Baudin's co-authors include Martin Faßnacht, Harm R. Haak, Massimo Terzolo, Guillaume Assié, Ronald R. de Krijger, Martin Schlumberger, Alfredo Berruti, Olaf M. Dekkers, Radu Mihai and Tobias Else and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Cancer and Endocrinology.

In The Last Decade

Eric Baudin

25 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors

2018 562 citations Martin Faßnacht, Eric Baudin et al. European Journal of Endocrinology profile →
Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

2020 238 citations Martin Faßnacht, Guillaume Assié et al. Annals of Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric Baudin France	16	1.6k	1.2k	1.1k	414	153	27	1.9k
Montserrat Ayala‐Ramirez United States	15	1.4k 0.9×	957 0.8×	1.1k 1.0×	161 0.4×	66 0.4×	24	1.6k
Esther Korpershoek Netherlands	24	1.2k 0.7×	1.0k 0.9×	820 0.7×	144 0.3×	291 1.9×	56	1.8k
Diana E. Benn Australia	25	1.3k 0.8×	1.2k 1.0×	968 0.9×	89 0.2×	432 2.8×	47	2.1k
Thereasa A. Rich United States	20	1.0k 0.6×	777 0.7×	948 0.8×	62 0.1×	183 1.2×	61	1.7k
Fernande René-Corail France	18	1.3k 0.8×	800 0.7×	782 0.7×	292 0.7×	390 2.5×	19	1.8k
Joakim Crona Sweden	21	946 0.6×	739 0.6×	778 0.7×	95 0.2×	112 0.7×	58	1.6k
Emília M. Pinto United States	20	488 0.3×	410 0.3×	352 0.3×	233 0.6×	376 2.5×	50	1.1k
Florence Tenenbaum France	20	734 0.5×	392 0.3×	669 0.6×	67 0.2×	54 0.4×	55	1.2k
Rodrigo A. Toledo Brazil	23	807 0.5×	762 0.6×	849 0.8×	71 0.2×	242 1.6×	61	1.7k
Francien H. van Nederveen Netherlands	20	700 0.4×	527 0.4×	531 0.5×	41 0.1×	159 1.0×	39	1.2k

Countries citing papers authored by Eric Baudin

Since Specialization

Citations

This map shows the geographic impact of Eric Baudin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Baudin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Baudin more than expected).

Fields of papers citing papers by Eric Baudin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Baudin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Baudin. The network helps show where Eric Baudin may publish in the future.

Co-authorship network of co-authors of Eric Baudin

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Baudin. A scholar is included among the top collaborators of Eric Baudin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Baudin. Eric Baudin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Porcelli, Tommaso, Sophie Moog, Julien Hadoux, et al.. (2025). Validation of the International Medullary Thyroid Carcinoma Grading System in Patients with Distant Metastases. Thyroid. 35(11). 1268–1276.

Faron, Matthieu, S. Hescot, Julien Hadoux, et al.. (2024). Prognostic value of total, free and lipoprotein fraction-bound plasma mitotane levels in advanced adrenocortical carcinoma: a prospective study of the ENDOCAN-COMETE-Cancer network. Journal of Endocrinological Investigation. 48(2). 357–367. 1 indexed citations

Libé, Rossella, Magalie Haissaguerre, Karine Renaudin, et al.. (2023). Recommandations conjointes du réseau National ENDOCAN-COMETE, de l’Association francophone de chirurgie endocrinienne et de la Société française d’urologie pour la prise en charge du carcinome corticosurrénalien. Bulletin du Cancer. 110(6). 707–730. 1 indexed citations

Faßnacht, Martin, Guillaume Assié, Eric Baudin, et al.. (2020). Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 31(11). 1476–1490. 238 indexed citations breakdown →

Gravel, Guillaume, Lambros Tselikas, Steven Yevich, et al.. (2019). Early detection with MRI of incomplete treatment of spine metastases after percutaneous cryoablation. European Radiology. 29(10). 5655–5663. 12 indexed citations

Berruti, Alfredo, Rossella Libé, Marta Laganà, et al.. (2019). Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: a multicenter retrospective study. European Journal of Endocrinology. 180(5). 311–320. 14 indexed citations

Hescot, S., Atmane Seck, Maryse Guérin, et al.. (2015). Lipoprotein-Free Mitotane Exerts High Cytotoxic Activity in Adrenocortical Carcinoma. The Journal of Clinical Endocrinology & Metabolism. 100(8). 2890–2898. 27 indexed citations

Baudin, Eric. (2015). Adrenocortical Carcinoma. Endocrinology and Metabolism Clinics of North America. 44(2). 411–434. 43 indexed citations

Hescot, S., Angélo Paci, Atmane Seck, et al.. (2014). The Lack of Antitumor Effects of o,p′DDA Excludes Its Role as an Active Metabolite of Mitotane for Adrenocortical Carcinoma Treatment. Hormones and Cancer. 5(5). 312–323. 21 indexed citations

10.

Berruti, Alfredo, Eric Baudin, Hans Gelderblom, et al.. (2012). Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 23. vii131–vii138. 217 indexed citations

11.

Baudin, Eric, Sophie Leboulleux, Abir Al Ghuzlan, et al.. (2011). Therapeutic Management of Advanced Adrenocortical Carcinoma: What Do We Know in 2011?. Hormones and Cancer. 2(6). 363–371. 29 indexed citations

12.

Fraipont, Florence de, Nadia Cherradi, G. Defaye, et al.. (2005). Gene Expression Profiling of Human Adrenocortical Tumors Using Complementary Deoxyribonucleic Acid Microarrays Identifies Several Candidate Genes as Markers of Malignancy. The Journal of Clinical Endocrinology & Metabolism. 90(3). 1819–1829. 185 indexed citations

13.

Faggiano, Antongiulio, Monique Talbot, Eric Baudin, et al.. (2003). Differential expression of galectin 3 in solid cell nests and C cells of human thyroid: Figure 1. Journal of Clinical Pathology. 56(2). 142–143. 13 indexed citations

14.

Baudin, Eric & Clarisse Dromain. (2002). Biologie et imagerie des tumeurs neuro-endocrines.. La Revue du praticien. 52(3). 1 indexed citations

15.

Baudin, Eric, Gabriella Pellegriti, M. Bonnay, et al.. (2001). Impact of monitoring plasma 1,1-dichlorodiphenildichloroethane (o,p?DDD) levels on the treatment of patients with adrenocortical carcinoma. Cancer. 92(6). 1385–1392. 172 indexed citations

16.

Boulle, Nathalie, Eric Baudin, Christine Gicquel, et al.. (2001). Evaluation of plasma insulin-like growth factor binding protein-2 as a marker for adrenocortical tumors. European Journal of Endocrinology. 144(1). 29–36. 39 indexed citations

17.

Baudin, Eric & François Degorce. (2001). Méthodologie et utilisation du dosage de la chromogranine A en biologie clinique.. médecine/sciences. 17(4). 438–438. 1 indexed citations

18.

Baudin, Eric, R. Cohen, N. Barbot, et al.. (1998). Pentagastrin Testing in Patients with Renal Insufficiency: Normal Responsivity of Mature Calcitonin. Thyroid. 8(3). 265–268. 17 indexed citations

19.

Bonacci, R, Anna Rita Gigliotti, Eric Baudin, et al.. (1998). Cytotoxic therapy with etoposide and cisplatin in advanced adrenocortical carcinoma. British Journal of Cancer. 78(4). 546–549. 60 indexed citations

20.

Schlumberger, Martin, Francesco Mancusi, Eric Baudin, & Furio Pacini. (1997). ¹³¹ I Therapy for Elevated Thyroglobulin Levels. Thyroid. 7(2). 273–276. 157 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact